|
Solifenacin EP Impurity A
|
(S)-1-苯基-1,2,3,4-四氫異喹啉
|
118864-75-8
|
|
Dexamethasone Acetate EP Impurity E
|
醋酸奧曲肽雜質(zhì)
|
1524-94-3
|
|
Dexamethasone Acetate EP Impurity F
|
地塞米松醋酸鹽EP雜質(zhì)F
|
2884-51-7
|
|
Dexamethasone Acetate EP Impurity G
|
地塞米松酮雜質(zhì)G
|
1597-78-0
|
|
Dexamethasone Acetate EP Impurity I
|
9-氟-11BETA,17,21-三羥基-16ALPHA-甲基孕甾-1,4-二烯-3,20-二酮 11,21-二乙酸酯
|
3949-26-6
|
|
Montelukast EP Impurity C
|
孟魯斯特亞砜
|
909849-96-3
|
|
Palbociclib Impurity 18
|
帕布昔利布雜質(zhì)50
|
2781952-66-5
|
|
Palbociclib Impurity 25
|
帕布昔利布雜質(zhì)9
|
2204368-66-9
|
|
Palbociclib Impurity 26
|
Palbociclib Impurity N-Oxide
|
2174002-29-8
|
|
Palbociclib Impurity 27
|
帕布昔利布雜質(zhì)46
|
571191-15-6
|
|
Palbociclib Impurity 28
|
Palbociclib impurity 33
|
1974279-40-7
|
|
Fenofibrate Impurity 4
|
非諾貝特雜質(zhì)
|
61002-27-5
|
|
Fenofibrate Impurity 6
|
非諾貝特雜質(zhì)16
|
62809-67-0
|
|
Fenofibrate Impurity 8
|
2-氯膽堿非諾貝特
|
61024-31-5
|
|
Solifenacin EP Impurity B
|
索利那新雜質(zhì) 1
|
1353274-25-5
|
|
Solifenacin EP Impurity C
|
索利那新雜質(zhì) B
|
1534326-81-2
|
|
Solifenacin EP Impurity E
|
(R)-(-)-3-奎寧醇
|
25333-42-0
|
|
Solifenacin EP Impurity F Succinate
|
索非那新琥珀酸相關(guān)物質(zhì)2
|
1262506-09-1
|
|
Solifenacin EP Impurity G Succinate
|
索非那新琥珀酸相關(guān)物質(zhì)3
|
862207-70-3
|
|
Solifenacin EP Impurity H
|
索利那新-索非那新雜質(zhì)
|
732228-02-3
|
|
Amiodarone EP Impurity B
|
去乙基胺碘酮
|
83409-32-9
|
|
Amiodarone EP Impurity C
|
單碘胺碘酮
|
85642-08-6
|
|
Amiodarone EP Impurity F
|
胺碘酮雜質(zhì)F
|
147030-50-0
|
|
Amiodarone EP Impurity G
|
胺碘酮雜質(zhì)G
|
1087223-70-8
|
|
Dabigatran Impurity 6
|
達比加群酯中間體3
|
1307233-94-8
|
|
Azacitidine Impurity 13
|
阿扎胞苷雜質(zhì)
|
65126-88-7
|
|
Azacitidine Impurity 17
|
|
178671-77-7
|
|
Azacitidine Impurity 18
|
AZACITIDINE IMPURITY 18
|
97818-29-6
|
|
Azacitidine Impurity 20
|
beta-D-Ribofuranose (9CI)
|
36468-53-8
|
|
Nimodipine Impurity 18
|
馬尼地平雜質(zhì)3
|
119128-13-1
|
|
Nimodipine Impurity 19
|
1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3,5-dicarboxylic acid monoisopropyl ester
|
116983-17-6
|
|
Nimodipine Impurity 20
|
尼莫地平雜質(zhì)30
|
1369507-43-6
|
|
Nimodipine Impurity 21
|
3-(2-hydroxyethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
|
85677-95-8
|
|
Teneligliptin Impurity 12
|
(2S,4R)-4-(4-(3-甲基-1-苯基-1H-吡唑-5-基)哌嗪-1-基)-2-(噻唑烷-3
|
1404559-22-3
|
|
Carfilzomib Impurity 5
|
(S)-4-(叔丁氧羰基氨基)-2,6-二甲基-1-庚烯-3-酮
|
247068-81-1
|
|
Carfilzomib Impurity 6
|
((1S)-3-甲基-1-(((2R)-2-甲基環(huán)氧乙基)羰基)丁基)氨基甲酸叔丁酯
|
247068-82-2
|
|
Azacitidine Impurity 4
|
阿扎胞苷相關(guān)化合物C(異構(gòu)體3)
|
2775292-14-1
|
|
Azacitidine USP Related Compound A
|
5-氮雜胞嘧啶
|
931-86-2
|
|
Azacitidine USP Related Compound C
|
阿扎胞苷雜質(zhì)
|
2508-80-7
|
|
Azacitidine Triacetate
|
三乙?；?阿扎胞苷
|
10302-78-0
|
|
Azacitidine Impurity 7
|
阿扎胞苷雜質(zhì)3
|
157771-77-2
|
|
Azacitidine Impurity 8
|
Azacitidine Impurity 37
|
206269-46-7
|
|
Azacitidine Impurity 11
|
阿扎胞苷雜質(zhì)34
|
105330-94-7
|
|
Azacitidine Impurity 12
|
阿扎胞苷雜質(zhì)40
|
2306050-23-5
|
|
Mometasone Furoate EP Impurity K
|
莫美他松EP雜質(zhì)K
|
4647-20-5
|
|
Bisoprolol Impurity 3
|
4-異丙氧基乙氧基甲基酚
|
177034-57-0
|
|
Fosfomycin Trometamol EP Impurity D
|
磷霉素氨丁三醇EP雜質(zhì)D
|
1262243-12-8
|
|
Trometamol Impurity 1
|
2-(羥基氨基)-2-(羥甲基)丙烷-1,3-二醇
|
65102-51-4
|
|
Dronedarone Impurity 5
|
N-[2-丁基-3-[4-[3-(丁基氨基)丙氧基]苯甲酰基]-5-苯并呋喃基]甲磺酰胺
|
141626-35-9
|
|
N-Nitroso-Varenicline
|
伐尼克蘭雜質(zhì)20
|
2755871-02-2
|
|
Ibrutinib Impurity 12
|
依魯替尼雜質(zhì)9
|
2031255-23-7
|
|
Ibrutinib Impurity 21
|
伊布替尼雜質(zhì)21
|
2052279-49-7
|
|
Noradrenaline EP Impurity B
|
2-氨基-1-(3,4-二羥基苯基)乙烷-1-酮
|
499-61-6
|
|
Noradrenaline EP Impurity C
|
2-(3,4-二羥基苯基)乙胺
|
51-61-6
|
|
Noradrenaline EP Impurity D
|
去甲腎上腺素EP雜質(zhì)E
|
1932110-67-2
|
|
Noradrenaline EP Impurity F
|
二芐胺
|
103-49-1
|
|
Noradrenaline EP Impurity G
|
去甲腎上腺素EP雜質(zhì)G
|
13062-58-3
|
|
Norepinephrine Impurity 3
|
去甲腎上腺素雜質(zhì)2
|
408328-15-4
|
|
Norepinephrine Impurity 4
|
腎上腺素雜質(zhì)S
|
74571-90-7
|
|
Norepinephrine Impurity 5
|
3,4-二羥基苯乙酮
|
1197-09-7
|
|
Quetiapine EP Impurity C
|
喹硫平雜質(zhì)18
|
1798840-31-9
|
|
Quetiapine EP Impurity D
|
喹硫平二聚物雜質(zhì)
|
945668-94-0
|
|
Quetiapine EP Impurity G
|
二苯并[b,f][1,4]硫氮雜卓-11-[10H]酮
|
3159-07-7
|
|
Quetiapine EP Impurity H
|
奎硫平N -氧化物
|
1076199-40-0
|
|
Quetiapine EP Impurity I
|
奎硫平去羥乙基雜質(zhì)
|
329216-67-3
|
|
Quetiapine EP Impurity R
|
富馬酸單乙酯
|
2459-05-4
|
|
Quetiapine EP Impurity T
|
喹硫平雜質(zhì)T
|
5747-46-6
|
|
Citalopram EP Impurity D
|
去甲基西酞普蘭
|
62498-67-3
|
|
Zopiclone EP Impurity A
|
N-氧化佐匹克隆
|
43200-96-0
|
|
Cyclophosphamide USP Related Compound B
|
環(huán)磷酰胺相關(guān)化合物B
|
158401-52-6
|
|
Cyclophosphamide USP Related Compound D
|
環(huán)磷酰胺相關(guān)化合物D
|
158401-51-5
|
|
Cyclophosphamide Impurity 1
|
環(huán)磷酰胺雜質(zhì)27 HCL
|
2387771-95-9
|
|
Cyclophosphamide Impurity 2
|
PHOSPHORODIAMIDIC ACID,N,N-BIS(2-CHLOROETHYL)-N'-(3-HYDROXYPROPYL)-
|
14504-75-7
|
|
Cyclophosphamide Impurity 3
|
Cyclophosphamide Impurity 8
|
90632-33-0
|
|
Cyclophosphamide Impurity 7
|
環(huán)磷酰胺雜質(zhì)26
|
2387771-94-8
|
|
Cyclophosphamide Impurity 9
|
環(huán)磷酰胺雜質(zhì)20
|
2387771-96-0
|
|
Cyclophosphamide Impurity 11
|
|
2517939-95-4
|
|
Cyclophosphamide Impurity 12
|
SWXKSMTWZSQXCQ-UHFFFAOYSA-N
|
1797009-12-1
|
|
Nimodipine EP Impurity A
|
尼莫地平雜質(zhì)A/二甲氧基-1-甲基乙基-2,6-二甲基-4-(3-硝基苯基)吡啶-3,5-二甲酸
|
85677-93-6
|
|
Nimodipine Impurity 12
|
Nimodipine Impurity 12
|
39562-18-0
|
|
Nimodipine Impurity 13
|
尼莫地平雜質(zhì)2
|
1316606-40-2
|
|
Nimodipine Impurity 14
|
尼莫地平雜質(zhì)3
|
2200280-99-3
|
|
Nimodipine Impurity 15
|
尼莫地平雜質(zhì)5
|
62760-08-1
|
|
Nimodipine Impurity 16
|
尼莫地平雜質(zhì)6
|
100287-10-3
|
|
Nimodipine Impurity 17
|
尼莫地平雜質(zhì)7
|
130773-01-2
|
|
Avanafil Impurity 10
|
阿伐那非中間體
|
330785-81-4
|
|
Avanafil Impurity 11
|
4-氯-2-甲硫基嘧啶-5-羧酸乙酯
|
5909-24-0
|
|
Fenofibrate Impurity 11
|
非諾貝特雜質(zhì)23
|
388632-17-5
|
|
Ketoprofen Impurity 24
|
(R)-Ketoprofen Acyl-β-D-glucuronide
|
140148-25-0
|
|
Ketoprofen Impurity 25
|
(S)-Ketoprofen Acyl-β-D-glucuronide
|
140148-26-1
|
|
Avanafil Impurity 1
|
阿伐那非雜質(zhì)34
|
38057-59-9
|
|
Avanafil Impurity 12
|
3-氯-4-甲氧基芐胺
|
115514-77-7
|
|
Avanafil Impurity 15
|
1,4-二氫-2-甲巰基-4-氧代-5-嘧啶甲酸乙酯
|
53554-29-3
|
|
Avanafil Impurity 18
|
L-脯氨醇
|
23356-96-9
|
|
Avanafil Impurity 19
|
D-脯氨醇
|
68832-13-3
|
|
Avanafil Impurity 20
|
5-嘧啶羧酸,4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2S)-2-(羥甲基)-1-吡咯]-乙酯
|
330785-83-6
|
|
Avanafil Impurity 24
|
330785-99-4
|
330785-99-4
|
|
Avanafil Impurity 25
|
Avanafil Impurity 17
|
2250242-12-5
|
|
Avanafil Impurity 26
|
(S)-4-(3-氯-4-甲氧基苯氨基)-5-羧基-2-(2-羥甲基-1-吡咯基)嘧啶
|
330785-84-7
|
|
Avanafil Impurity 27
|
2,4-雙((3-氯-4-甲氧基芐基)氨基)嘧啶-5-羧酸
|
1643811-21-5
|